Ask Warren

Aligned Genetics

238120 · KOSDAQ · ₩238120 · 얼라인드

₩2,435▼ ₩90 (3.56%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩4.4B₩3.6B₩4.3B₩3.9B₩3.9B₩3.9B₩5.6B₩3.7B
Cost of sales₩1.1B₩953M₩1.3B₩964M₩1.2B₩1.4B₩1.8B₩945M
Gross profit₩3.2B₩2.7B₩3B₩2.9B₩2.7B₩2.6B₩3.8B₩2.8B
Operating income₩644M₩230M₩1.1B₩545M₩260M₩531M₩1.6B₩760M
Net income₩1.7B₩418M₩2B₩1.1B−₩671M₩554M₩3.6B−₩114M
Net income to shareholders₩1.7B₩418M₩1.5B₩933M−₩117M₩554M₩2.4B₩507M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩60B₩59B₩58B₩45B₩44B₩44B₩44B₩41B
Current assets₩25B₩24B₩23B₩26B₩25B₩25B₩26B₩22B
Cash and equivalents₩11B₩11B₩15B₩15B₩13B₩13B₩10B₩15B
Total liabilities₩21B₩21B₩21B₩9.6B₩8.9B₩8.8B₩8.8B₩8.2B
Current liabilities₩4.6B₩4.8B₩4.5B₩2.6B₩2B₩1.7B₩1.9B₩1.2B
Borrowings₩12B₩12B₩12B₩2.4B₩2.4B₩2.4B₩2.4B₩2.4B
Total equity₩39B₩38B₩37B₩35B₩35B₩35B₩35B₩33B
Shareholders' equity₩39B₩38B₩37B₩35B₩35B₩35B₩35B₩33B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩428M₩25M₩4.6B−₩2B₩677M₩351M₩1.6B₩975M
Capital spending—————₩195M₩71M₩76M
Free cash flow₩428M₩25M₩4.6B−₩2B₩677M₩156M₩1.5B₩899M

Consolidated where available. Amounts in won.

Also known as: Aligned Genetics / 얼라인드 / 238120 / KRX:238120

Source: KRX statistical information